ANALYSIS: next steps to move EU medtech regulations forward and key player views
This article was originally published in Clinica
Executive Summary
What is going to happen next with the EU’s proposed Medical Device and IVD Regulations and who is going to influence the way forward? Amanda Maxwell looks at how member states have spread their cards on the table, the main stumbling blocks ahead and how the cost of implementing the Regulations is moving up the EU agenda.
You may also be interested in...
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.
First Danish Notified Body Named Under EU's Medical Device Regulation
The EU now has a total of 45 notified bodies under the MDR.